RNA interference for the treatment of papillomavirus disease.

The Open Virology Journal Pub Date : 2012-01-01 Epub Date: 2012-12-28 DOI:10.2174/1874357901206010204
Richa Singhania, Norliana Khairuddin, Daniel Clarke, Nigel Aj McMillan
{"title":"RNA interference for the treatment of papillomavirus disease.","authors":"Richa Singhania,&nbsp;Norliana Khairuddin,&nbsp;Daniel Clarke,&nbsp;Nigel Aj McMillan","doi":"10.2174/1874357901206010204","DOIUrl":null,"url":null,"abstract":"<p><p>Human Papillomavirus (HPV)-induced diseases are a significant burden on our healthcare system and current therapies are not curative. Vaccination provides significant prophylactic protection but effective therapeutic treatments will still be required. RNA interference (RNAi) has great promise in providing highly specific therapies for all HPV diseases yet this promise has not been realised. Here we review the research into RNAi therapy for HPV in vitro and in vivo and examine the various targets and outcomes. We discuss the idea of using RNAi with current treatments and address delivery of RNAi, the major issue holding back clinical adoption. Finally, we present our view of a potential path to the clinic.</p>","PeriodicalId":23111,"journal":{"name":"The Open Virology Journal","volume":"6 ","pages":"204-15"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/12/78/TOVJ-6-204.PMC3547394.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Virology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874357901206010204","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/12/28 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Human Papillomavirus (HPV)-induced diseases are a significant burden on our healthcare system and current therapies are not curative. Vaccination provides significant prophylactic protection but effective therapeutic treatments will still be required. RNA interference (RNAi) has great promise in providing highly specific therapies for all HPV diseases yet this promise has not been realised. Here we review the research into RNAi therapy for HPV in vitro and in vivo and examine the various targets and outcomes. We discuss the idea of using RNAi with current treatments and address delivery of RNAi, the major issue holding back clinical adoption. Finally, we present our view of a potential path to the clinic.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
RNA干扰治疗乳头瘤病毒病。
人乳头瘤病毒(HPV)引起的疾病是我们医疗保健系统的一个重大负担,目前的治疗方法无法治愈。疫苗接种提供了重要的预防性保护,但仍需要有效的治疗方法。RNA干扰(RNAi)在为所有HPV疾病提供高度特异性治疗方面有很大的希望,但这一希望尚未实现。本文综述了体外和体内RNAi治疗HPV的研究进展,并探讨了各种靶点和结果。我们讨论了在当前治疗中使用RNAi的想法,并解决了RNAi的递送问题,这是阻碍临床采用的主要问题。最后,我们提出了我们的观点,一个潜在的路径到诊所。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Evolutionary Significance of Generalist Viruses with Special Emphasis on Plant Viruses and their Hosts Strategies and Challenges to Develop Therapeutic Candidates against COVID-19 Pandemic Iota-Carrageenan as an Antiviral Treatment for the Common Cold A Summary of Viral Targets and Recently Released PDB IDs of SARS-CoV-2 Evolving Rotaviruses, Interspecies Transmission and Zoonoses
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1